Eric L. Moore

HC-030031, a TRPA1 Selective Antagonist, Attenuates Inflammatory- and Neuropathy-Induced Mechanical Hypersensitivity

Samer R. Eid, Eric D. Crown, Eric L. Moore et al. · Molecular Pain · 2008 · 441 citations · Full text

Structural basis for selectivity and diversity in angiotensin II receptors

Haitao Zhang, Gye Won Han, A. Batyuk et al. · Nature · 2017 · 212 citations · Full text

Molecular Physiology, Signal Transduction, G Protein-coupled Receptor +9

Pharmacological Characterization of MK-0974 [N-[(3 R,6 S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1 H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist for the Treatment of Migraine

Christopher Salvatore, James C. Hershey, Halea A. Corcoran et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 145 citations

Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells

Murielle Mimeault, Sonny L. Johansson, Ganesh Vankatraman et al. · Molecular Cancer Therapeutics · 2007 · 91 citations · Full text

Pharmacological Properties of MK-3207, a Potent and Orally Active Calcitonin Gene-Related Peptide Receptor Antagonist

Christopher Salvatore, Eric L. Moore, Amy Calamari et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 88 citations